alexa The Epidemiology Of HCV And PWIDs In The United States
ISSN: 2167-0889

Journal of Liver
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

CO-ORGANIZED EVENT: 5th World Congress on Hepatitis & Liver Diseases & 2nd International Conference on Pancreatic Cancer & Liver Diseases
August 10-12, 2017 London, UK

Seth Kuranz, Ruchika Sharma and Michael Hughes
Decision Resources Group, USA
ScientificTracks Abstracts: J Liver
DOI: 10.4172/2167-0889-C1-014
Abstract
Introduction: In developed countries, persons who inject drugs (PWIDs) are at highest risk of contracting HCV. In the US, persons who ever injected drugs had almost 30 times the risk of a positive HCV antibody test. Although incidence and prevalence of HCV is decreasing in the developed countries, access to care among the PWID population limits even greater reductions in the incidence of HCV. This, in addition to increasing rates of IDU in the US, means PWIDs are an important population for prevention and clinical intervention. Methods: The National Health and Nutrition Examination Survey (NHANES) is a nationally representative study of the noninstitutionalized US population. We used NHANES 1999-2010 to assess the prevalence of PWIDs among adults with viremic HCV. We also used the national death index, linked to NHANES by the NCHS, to examine mortality in this population using a Cox Proportional Hazards model. Results: The prevalence of PWIDs with viremic HCV between 1999 and 2010 in the US was 2.6 per 1.000 persons. By 2010, 9.1% of PWIDs with HCV were assumed to be deceased. Injecting drugs among the viremic HCV population in the US was associated with an increased rate of mortality [HR: 2.5 (95% CI: 1.8, 3.7)], adjusting for age and gender. Conclusion: There is excess mortality among the PWID/HCV population in the US. Since 2010, mortality rates have climbed due to both opiate prescribing practices, and the introduction of fentanyl into the illicit opioid drug market. Although PWIDs have a higher risk of both HCV and mortality, adherence to DAAs is similar in PWID and non-PWID populations, suggesting interventions are effective. These results will be discussed in the broader context of HCV epidemiology in the US and Europe.
Biography

Seth Kuranz is an Epidemiologist at DRG specializing in Epidemiology of Metabolic, Renal and Psychiatric Disorders. He holds an MPH (Master of Public Health) degree from Boston University. He previously served as the Coordinator of an international research project focusing on early adult development and substance abuse dependence.

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version